# The Efficacy and Tolerability of 12-weeks Treatment With Almond and Buckwheat Based Formula in Pediatric Patients With Active EoE

> **NCT05622214** · NA · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 20 (estimated)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DIETARY_SUPPLEMENT:** Else nutrition formula

## Key facts

- **NCT ID:** NCT05622214
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-25
- **Primary completion:** 2023-07-24
- **Final completion:** 2023-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05622214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05622214, "The Efficacy and Tolerability of 12-weeks Treatment With Almond and Buckwheat Based Formula in Pediatric Patients With Active EoE". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05622214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*